#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor

According to scientists from the United Kingdom, a simple test based on an individual's skin odor could aid the early diagnosis of Parkinson's disease. A study has already been launched to investigate the chemicals secreted by the skin of patients with Parkinson's disease.
Source: Parkinson's Disease 2. 12. 2020

News What Did the Patent for the Synthesis of Highly Purified Trazodone Bring?

Trazodone is a modern antidepressant that is used in the treatment of various types of depression, including those accompanied by anxiety, sleep disorders, or sexual dysfunction. Angelini's invention, with patent protection valid until 2028, presents several methods for the preparation of purified trazodone, or trazodone hydrochloride, which guarantees high purity of this substance and a low content of unwanted residues.
Source: Depression and Anxiety 5. 10. 2020

News Potential of Enoxaparin to Maintain A-V Shunt Patency According to the SEP Protocol

A newly published study by authors from Singapore focused on the ability of the SEP protocol – short-term low-dose enoxaparin administration based on body weight – to maintain the patency of an arteriovenous (A-V) shunt after recurrent thrombosis.
Source: Thromboprophylaxis 3. 1. 2024

Journal articles Promising treatment modalities in the therapy of myelodysplastic syndromes

Author of the article: A. Jonášová Source: Klinická onkologie | 5/2021 18. 10. 2021

Journal articles Proton radiation therapy in the treatment of solid tumours

Author of the article: J. Kubeš, V. Vondráček, J. Abrahámová Source: Praktický lékař | 1/2019 28. 12. 2018

Journal articles Some Controversies in Gynecology and Obstetrics

Author of the article: M. Velemínský ml., M. Velemínský st. Source: Česko-slovenská pediatrie | 10/2010 9. 10. 2010

Journal articles The importance of oral hygiene in the prevention of plaque induced oral cavity diseases

Author of the article: M. Nedvědová Source: Praktický lékař | 3/2008 31. 3. 2008

News Current and Future Possibilities for Influencing Immune Thrombocytopenia

The possibilities for treating immune thrombocytopenia (ITP) are quite broad today, with a major advancement for many patients being the advent of thrombopoietin receptor agonists. However, for some patients, optimal treatment is still not available, and their hope lies in further research.
Source: Immune Thrombocytopenia 16. 5. 2022

News Administration of Low-Molecular-Weight Heparin After Hemorrhagic Stroke: What Is the Appropriate Timing?

Hemorrhagic stroke (HS) is a condition that raises doubts and concerns about anticoagulation. Is early prevention of thromboembolic complications appropriate?
Source: Thromboprophylaxis 30. 9. 2021

News Alemtuzumab – Does Age Matter? Or Not?

The authors of a study published this year focused on the safety and efficacy of alemtuzumab in patients with relapsing-remitting multiple sclerosis (RRMS). How did it perform over the observed period in patients of different age categories?
Source: Multiple Sclerosis 18. 10. 2021

News How to vaccinate children against pneumococcus?

Pneumococcus is a dreaded pathogen causing serious diseases in pediatric patients. However, it can be effectively prevented with commonly available vaccines. Let's look at the updated recommendation of the Czech Vaccinological Society ČLS JEP from April this year.
Source: Regular Vaccination 30. 5. 2024

News Colours of Sepsis 2023: Antimicrobial Stewardship is a Necessity. The Spectrum of Effective Antimicrobial Modalities has Expanded to Include Another Combination

Inappropriate antibiotic (ATB) treatment is associated with high mortality, while unrestricted use of broad-spectrum antibiotics drives resistance development. Thus, the decision to deploy antibiotics becomes a choice between the current and future patient. Antimicrobial stewardship (AMS) is an essential strategy in daily operations. Extending the spectrum of antimicrobial agents is equally crucial in combatting resistant bacterial strains. A symposium on this theme was part of the expert program at this year's 'festival of intensive medicine' Colours of Sepsis, held in late January in Ostrava.
Source: Anti-Infectives 9. 2. 2023

News Interchangeability of Diosmin and Micronized Purified Flavonoid Fraction

Among the medicinal products reimbursed for chronic venous disease, those containing micronized diosmin (Diozen 180 tbl.) have been newly included. Which substances are available for this indication, and what determined the interchangeability of micronized diosmin with micronized purified flavonoid fraction (MPFF) and other selected venotonics stabilizing capillaries?
Source: Venous Insufficiency 16. 9. 2022

Journal articles Definition of sepsis and septic shock

Author of the article: M. Holub Source: Klinická biochemie a metabolismus | 2/2018 10. 4. 2018

News Risk of Thromboembolism in ITP

Among other possible comorbidities in patients with ITP, thromboembolism represents one of the potential issues that require special attention.
Source: Immune Thrombocytopenia 7. 3. 2021

News EAHAD 2024: Fresh results of paradigm5 and 6 studies confirm safety and efficacy of N9-GP

Nonacog beta pegol (N9-GP) is a recombinant factor IX with an extended half-life. Its properties allow for the maintenance of a satisfactorily high level of FIX with intravenous application once a week. At the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), held in early February 2024 in Frankfurt, new findings on this treatment were presented during a satellite symposium by Novo Nordisk.
Source: Hemophilia with Movement 30. 4. 2024

News Postpartum Uterine Artery Pseudoaneurysm in a Woman with vWD – Case Study

Women with von Willebrand disease (vWD) have a significantly higher risk of postpartum hemorrhage. American experts from University Hospital in Augusta have published their experience with an unusual case of secondary postpartum hemorrhage in a young woman with type 1 vWD.
Source: Von Willebrand Disease 28. 6. 2023

News INFOGRAPHIC: Post-Induction Therapy for AML – Current Guidelines

What are the recommended therapeutic modalities for consolidation and maintenance therapy of acute myeloid leukemia (AML) in patients over 60 years of age? We present a clear therapeutic algorithm according to the current recommendations of the American National Comprehensive Cancer Network.
Source: Acute Myeloid Leukemia 10. 10. 2023

News Long-term Clinical and Radiological Results of Implantation of Cementless Corail Stem

The Corail femoral stem with extensive hydroxyapatite coating for cementless implantation was introduced to the market several decades ago. The study cited below evaluated the clinical and radiological results of the implantation of this type of stem over a 20-year horizon in patients who underwent primary total hip arthroplasty.
Source: Large Joints 2. 10. 2020

News INFOGRAPHIC: Eye Drops for Dry and Irritated Eyes – Mechanism of Action and Benefits

Source: Ophthalmologic Diseases 2. 5. 2023

News Dabigatran vs. Warfarin: What and Why Do Patients Prefer?

The key to adherence to long-term anticoagulant therapy is primarily the satisfaction of patients with the set therapy. The RE-SONANCE study published in April 2021 compared patient satisfaction with anticoagulant treatment using the direct oral anticoagulant (DOAC) dabigatran versus vitamin K antagonists (VKAs). What were the findings?
Source: Anticoagulant Treatment 1. 7. 2021

News Romiplostim in Newly Diagnosed ITP Resistant to 1st Line Treatment – Case Study

In patients with immune thrombocytopenia (ITP), effectively stopping and controlling bleeding can be complicated in some cases. This includes scenarios such as open wounds. One way to stabilize platelet count can be through administering a thrombopoietin receptor agonist (TPO-RA). The following case study presents a successful treatment of newly diagnosed ITP.
Source: Immune Thrombocytopenia 2. 10. 2023

News Treatment of Schizophrenia in a Patient at Risk of Developing Metabolic Syndrome – Interactive Case Study

A 34-year-old man has been under psychiatric care for 3 years due to a psychotic disorder. Three years ago, he had his first short hospitalization due to marked paranoid symptoms: feelings of being watched, eavesdropping, auditory hallucinations of an imperative nature...
Source: Modern Treatment of Schizophrenia 17. 7. 2023

Journal articles Diabetes and Schizophrenia

Author of the article: L. Ustohal1ihash2 Source: Česká a slovenská neurologie a neurochirurgie | 1/2012 20. 1. 2012

News Can SGLT2 Inhibition Also Reduce the Risk of Nephrolithiasis?

Diabetes mellitus (DM) is a risk factor for the development of nephrolithiasis. Recent studies associated with nephrolithiasis suggest a possible beneficial effect of sodium-glucose cotransporter 2 inhibitors (SGLT2i, also known as gliflozins), a significant group of modern antidiabetics. Below we summarize findings from a study that explored this potential in empagliflozin using conducted phase I–IV studies, including EMPA-REG OUTCOME.
Source: Diabetes 21. 8. 2023

1 37 38 39 40 41 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#